[1]
Choudhary, M.I.; Naheed, S.; Jalil, S.; Alam, J.M. Effects of ethanolic extract of Iris germanica on lipid profile of rats fed on a high-fat diet. J. Ethnopharmacol., 2005, 98(1-2), 217-220.
[2]
Jakulj, F.; Zernicke, K.; Bacon, S.L.; Van Wielingen, L.E.; Key, B.L.; West, S.G.; Campbell, T.S. A high-fat meal increases cardiovascular reactivity to psychological stress in healthy young adults. J. Nutr., 2007, 137(4), 935-939.
[3]
Kabiri, N.; Asgary, S.; Madani, H.; Mahzouni, P. Effects of Amaranthuscaudatusl. Extract and lovastatin on atherosclerosis in hypercholesterolemic rabbits. J. Med. Plants Res., 2010, 4(3), 55-61.
[4]
Hopps, E.; Noto, D.; Caimi, G.; Averna, M.R. A novel component of the metabolic syndrome: The oxidative stress. Nutr. Metab. Cardiovasc. Dis., 2010, 20(1), 72-77.
[5]
Galili, O.; Versari, D.; Sattler, K.J.; Olson, M.L.; Mannheim, D.; McConnell, J.P.; Chade, A.R.; Lerman, L.O.; Lerman, A. Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. Am. J. Physiol. Heart Circ. Physiol., 2007, 292(2), H904-H911.
[6]
Chakraborti, D.; Verma, R. Ameliorative effect of Emblica officinalis aqueous extract on ochratoxin-induced lipid peroxidation n the kidney and liver of mice. Int. J. Occup. Med. Environ. Health, 2010, 23(1), 63-73.
[7]
Lankin, V.Z.; Tikhaze, A.K.; Kukharchuk, V.V.; Konovalova, G.G.; Pisarenko, O.I.; Kaminnyi, A.I.; Shumaev, K.B.; Belenkov, Y.N. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins. Mol. Cell. Biochem., 2003, 249(1-2), 129-140.
[8]
Kanthe, P.S.; Patil, B.S.; Bagali, S.C.; Reddy, R.C.; Aithala, M.R.; Das, K.K. Protective effects of ethanolic extract of Emblica officinalis (amla) on cardiovascular pathophysiology of rats, fed with high fat diet. J. Clin. Diagn. Res., 2017, 11(9), CC05.
[9]
Antony, B.; Merina, B.; Sheeba, V.; Mukkadan, J. Effcet of standardized Amla extract on atherosclerosis and dyslipidemia. Indian J. Pharm. Sci., 2006, 68(4), 437-441.
[10]
Kanthe, P.S.; Patil, B.S.; Aithala, M.R.; Das, K.K. Effect of ethanolic extract of Emblica officinalis (amla) on glucose homeostasis in rats fed with high fat diet. J. Krishna Inst. Med. Sci. Univ., 2017, 6(3), 31-37.
[11]
Tiwari, P.; Kumar, B.; Kaur, M.; Kaur, G.; Kaur, H. Phytochemical screening and extraction: A review. Int. Pharm. Sci., 2011, 1, 103-104.
[12]
Das, K.K.; Dasgupta, S. Effect of nickel sulfate on testicular steroidogenesis in rats during protein restriction. Environ. Health Perspect., 2002, 110(9), 923-926.
[13]
Pingali, U.; Fatima, N.; Murlidhar, N. Effects of phyllanthus Emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: A randomized, double-blind, controlled study. Diab. Metab. Syndrome Obesity: Target Ther., 2013, 6, 275-284.
[14]
Okhawa, H.; Ohishi, N.; Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 1979, 95(2), 351-358.
[15]
Hayashi, K.; Mani, V.; Nemade, A.; Aguiar, S.; Postley, J.E.; Fuster, V.; Fayad, Z.A. Variations in atherosclerosis and remodeling patterns in aorta and carotids. J. Cardiovasc. Magn. Reson., 2010, 12(1), 10.
[17]
Collins, P. Risk factors for cardiovascular disease and hormone therapy in women. Heart, 2006, 92(3), 24-28.
[18]
Rajak, S.; Banerjee, S.K.; Sood, S.; Dinda, A.K.; Gupta, Y.K.; Gupta, S.K.; Maulik, S.K. Emblica officinalis causes myocardial adaptation and protects against oxidative stress in ischemic‐reperfusion injury in rats. Phytother. Res. Int. J. Pharmacol. Toxicol. Eval. Nat. Prod. Derivatives, 2004, 18(1), 54-60.
[19]
Nascimento, T.B.; Baptista, R.D.; Pereira, P.C.; Campos, D.H.; Leopoldo, A.S.; Leopoldo, A.P.; Oliveira Junior, S.A.; Padovani, C.R.; Cicogna, A.C.; Cordellini, S. Vascular alterations in high fat diet obese rats: Role of endothelial L-arginine/NO pathway. Arq. Bras. Cardiol., 2011, 97(1), 40-45.
[20]
Radomski, M.W.; Palmer, R.M.; Moncada, S. The anti-aggregating properties of vascular endothelium: Interactions between prostacyclin and nitric oxide. Br. J. Pharmacol., 1987, 92, 639-646.
[21]
Nakaki, T.; Nakayama, M.; Kato, R. Inhibition by nitric oxide and nitric oxide producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur. J. Pharmacol. Mol. Pharmacol., 1990, 189, 347-353.
[22]
Mueller, C.F.; Laude, K.; McNally, J.S.; Harrison, D.G. Redox mechanism in blood vessels. Arterioscler. Thromb. Vasc. Biol., 2005, 25, 274-278.
[23]
Payne, G.A.; Bohlen, H.G.; Dincer, U.D.; Borbouse, L.; Tune, J.D. Periadventitial adipose tissue impairs coronary endothelial function via PKC ß-dependent phosphorylation of nitric oxide synthase. Am. J. Physiol. Heart Circ. Physiol., 2009, 297(1), 460-465.
[24]
Hosogai, N.; Fukuhara, A.; Oshima, K.; Miyata, Y.; Tanaka, S.; Segawa, K.; Furukawa, S.; Tochino, Y.; Komuro, R.; Matsuda, M.; Shimomura, I. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes, 2007, 56(4), 901-911.
[25]
Vásquez, V.J.; Kalyanaraman, B.; Martásek, P.; Hogg, N.; Masters, B.S.; Karoui, H.; Tordo, P.; Pritchard, K.A. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. In: Proceedings of the National Academy of Sciences, 1998, 95(16), 9220-9225.
[26]
Das, K.K.; Chadchan, K.S.; Reddy, R.C.; Biradar, M.S.; Kanthe, P.S.; Patil, B.S.; Ambekar, J.G.; Bagoji, I.B.; Das, S.N. Effects of some indigenous plants of North Karnataka (India) on cardiovascular and glucose regulatory systems in alloxan-induced diabetic rats. Cardiovasc. Hematol. Agents Med. Chem., 2017, 15(1), 49-61.
[27]
Sultana, S.; Ahmad, S.; Khan, N.; Jahangir, T. Effects of Emblica officinalis (Gaertn) on CCl4-induced hepatic toxicity and DNA synthesis of Wistar rats. Indian J. Exp. Biol., 2005, 43, 430-436.
[28]
Kaur, J.; Kaur, D.; Singh, H.; Khan, M.U. Emblica officinalis: A
meritocratic drug for treating various disorders. Indo Am. J. Pharm. Res., 2013, 3(6)
[29]
Nampoothiri, S.V.; Prathapan, A.; Cherian, O.L.; Raghu, K.G.; Venugopalan, V.V.; Sundaresan, A. In vitro antioxidant and inhibitory potential of Terminalia bellerica and Emblica officinalis fruits against LDL oxidation and key enzymes linked to type 2 diabetes. Food Chem. Toxicol., 2011, 49(1), 125-131.
[30]
Townsend, R.R.; Wilkinson, I.B.; Schiffrin, E.L.; Avolio, A.P.; Chirinos, J.A.; Cockcroft, J.R.; Heffernan, K.S.; Lakatta, E.G.; McEniery, C.M.; Mitchell, G.F.; Najjar, S.S. Recommendations for improving and standardizing vascular research on arterial stiffness: A scientific statement from the American Heart Association. Hypertension, 2015, 66(3), 698-722.
[31]
Sentelices, L.C.; Rutaman, S.J.; Ertart, J.C.; Pranti, R.L.; Hanay, J.N.; Vorp, D.A.; Aharan, J.M. Experimental system for ex vivo measurement of Murine aortic stiffness. Physiol. Meas., 2007, 28(8), 39-49.
[32]
Haurington, J.; Pana, A.S.; Gent, R.; Hirtec, C.J. Aortic intima media thickness is an early marker of atherosclerosis in children with type 1 diabetes mellitus. J. Pedator., 2010, 156, 237-241.
[33]
Deopujari, R.; Dixit, A. The study of age related changes in coronary arteries and its relevance to the atherosclerosis. J. Anat. Soc. India, 2010, 59(2), 192-196.
[34]
Billaud, M.; Johnstone, S.R.; Isakson, B.E. Loss of compliance in small arteries, but not in conduit arteries, after 6 weeks exposure to high fat diet. J. Cardiovasc. Transl. Res., 2012, 5(3), 256-263.
[35]
Rizzoni, D.D.; Ciuceis, C.; Porteri, E.; Semerarao, F.; Rosri, E.A. Structural alterations in small resistance arteries in obesity. Basic Clin. Pharmacol. Toxicol., 2011, 1742-1843.
[36]
Waller, B.F.; Orr, C.M.; Slack, J.D.; Pinkerton, C.A.; Van, T.J.; Peters, T. Anatomy, histology, and pathology of coronary arteries: A review relevant to new interventional and imaging techniques-Part I. Clin. Cardiol., 1992, 15(6), 451-457.
[37]
Benditt, E.P.; Schwartz, S.M. Blood vessels. In:Pathology; (Eds.Rubin E, Farber JL) . JB Lippincott: Philadelphia, 1988, pp. 454-465.
[38]
Waller, B.F. The eccentric coronary atherosclerotic plaque morphologic observations and clinical relevance. Clin. Cardiol., 1989, 12, 14-20.
[39]
Leopold, J.A.; Loscalzo, J. Oxidative mechanisms and athero thrombotic cardiovascular disease. Drug Discov. Today Ther. Strateg., 2008, 5(1), 5-13.
[40]
Ross, R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med., 1999, 340(2), 115-126.
[41]
Oubina, M.P.; De Las Heras, N.; Cediel, E.; Sanz-Rosa, D.; Aragoncillo, P.; D’iaz, C.; Hernandez, G.; Lahera, V.; Cachofeiro, V. Synergetic effect of angiotensin converting enzyme ACE 3 hydroxy 3 mythelyne CoA HMG CoA reductase inhibition on inflammatory in atherosclerosis Rabbits. Clin. Sci., 2003, 105, 655-662.
[42]
Stocker, R.; Keaney, J.F. Role oxidative modifications in atherosclerosis. Physiol. Rev., 2004, 84, 1381-1478.
[43]
Saam, T.; Raya, J.G.; Cyran, C.C.; Bochmann, K.; Meimarakis, G.; Dietrich, O.; Clevert, D.A.; Frey, U.; Yuan, C.; Hatsukami, T.S.; Werf, A. High resolution carotid black-blood 3TMR with parallel imaging and dedicated 4-channel surface coils. J. Cardiovasc. Magn. Reson., 2009, 4(1), 11-41.